4.5 Article

The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells

Journal

TRANSLATIONAL ONCOLOGY
Volume 11, Issue 2, Pages 487-497

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.tranon.2018.02.002

Keywords

-

Categories

Funding

  1. National Science and Technology Major Project of the Ministry of Science and Technology of China [2017ZX09304025]
  2. Science and Technology Plan Project of Liaoning Province [2015020457]
  3. National Natural Science Foundation of China [81572374, 81372547, 81201615]
  4. Liaoning Province Department of Education [LZ2015073]
  5. Foundation for Selected Overseas Chinese Scholar
  6. Key Research and Development Program of Shenyang [17-230-9-01]

Ask authors/readers for more resources

The C-X-C motif chemokine receptor 4 (CXCR4) pathway can promote tumor metastasis but is dependent on cross talk with other signaling pathways. The MET proto-oncogene (c-MET) participates in metastasis and is highly expressed in gastric cancer. However, the relationship between CXCR4 and c-MET signaling and their mechanisms of action in gastric cancer metastasis remain unclear. In this study, in vitro experiments demonstrated that C-X-C motif chemokine ligand 12 (CXCL12)/CXCR4 induces epithelial-mesenchymal transition (EMT) and promotes migration in gastric cancer cells, which is accompanied by c-MET activation. These phenomena were reversed by c-MET inhibition. Further investigation revealed that c-MET activation correlated with its interaction with caveolin 1 in lipid rafts, induced by CXCL12. In clinical samples, we observed a significant positive association between CXCR4 expression and c-MET phosphorylation (r = 0.259, P =.005). Moreover, samples expressing both receptors were found to indicate significantly poorer patient prognosis (P < .001). These results suggest that CXCL12 induces EMT at least partially through cross talk between CXCR4 and c-MET signaling. In addition, changes in these pathways could have clinical importance for the treatment of gastric cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Microbiology

Role of abnormal microRNA expression in Helicobacter pylori associated gastric cancer

Dan Zou, Ling Xu, Heming Li, Yanju Ma, Yuehua Gong, Tianshu Guo, Zhitao Jing, Xiuying Xu, Ye Zhang

CRITICAL REVIEWS IN MICROBIOLOGY (2019)

Article Oncology

Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis

Yibo Fan, Xiaofang Che, Jinglei Qu, Kezuo Hou, Ti Wen, Zhi Li, Ce Li, Shuo Wang, Ling Xu, Yunpeng Liu, Xiujuan Qu

ANNALS OF SURGICAL ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

4-phenylbutyric acid promotes migration of gastric cancer cells by histone deacetylase inhibition-mediated IL-8 upregulation

Xiaonan Shi, Libao Gong, Yunpeng Liu, Kezuo Hou, Yibo Fan, Ce Li, Ti Wen, Xiujuan Qu, Xiaofang Che

EPIGENETICS (2020)

Article Plant Sciences

beta-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway

Mingming Deng, Bofang Liu, Huicong Song, Ruoxi Yu, Dan Zou, Yang Chen, Yanju Ma, Fei Lv, Ling Xu, Zhe Zhang, Qingjie Lv, Xianghong Yang, Xiaofang Che, Xiujuan Qu, Yunpeng Liu, Ye Zhang, Xuejun Hu

PHYTOMEDICINE (2020)

Article Oncology

PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells

Na Song, Ming Bai, Xiaofang Che, Zhi Li, Wei Jing, Ce Li, Zan Teng, Xiujuan Qu, Yunpeng Liu

MEDICAL ONCOLOGY (2020)

Article Oncology

Knockdown of G-protein-signaling modulator 2 promotes metastasis of non-small-cell lung cancer by inducing the expression of Snail

Mingming Deng, Bofang Liu, Zhe Zhang, Yang Chen, Yizhe Wang, Ximing Wang, Qingjie Lv, Xianghong Yang, Kezuo Hou, Xiaofang Che, Xiujuan Qu, Yunpeng Liu, Ye Zhang, Xuejun Hu

CANCER SCIENCE (2020)

Article Oncology

PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR

Jinqi Lv, Tianshu Guo, Xiujuan Qu, Xiaofang Che, Ce Li, Shuo Wang, Jing Gong, Peihong Wu, Yang Liu, Yunpeng Liu, Ling Xu

FRONTIERS IN ONCOLOGY (2020)

Review Pharmacology & Pharmacy

Pharmaceutical strategies in improving anti-tumour efficacy and safety of intraperitoneal therapy for peritoneal metastasis

Puxiu Wang, Xiujuan Qu, Xiaofang Che, Qiuhua Luo, Xing Tang, Yunpeng Liu

Summary: Despite showing promising potential in both mouse models and clinical trials, the clinical application of IP therapy for patients with PM is limited due to serious side effects and low acceptability. Further investigations, including pharmaceutical strategies, are needed to develop potential IP therapy solutions that focus on both efficacy and safety.

EXPERT OPINION ON DRUG DELIVERY (2021)

Article Oncology

Development and Validation of a Prognostic Nomogram for Gastric Signet Ring Cell Carcinoma: A Multicenter Population-Based Study

Shuairan Zhang, Yang Liu, Zihan Jiao, Zenan Li, Jin Wang, Ce Li, Xiujuan Qu, Ling Xu

Summary: This study identified seven independent prognostic factors of GSRCC and established corresponding nomogram models to help clinicians predict survival, showing good predictive value in comparison to the traditional AJCC staging system.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients

Shuo Wang, Xiujuan Qu, Zhi Li, Xiaofang Che, Lili Cao, Xianghong Yang, Xuejun Hu, Ling Xu, Kezuo Hou, Yibo Fan, Ti Wen, Yunpeng Liu

Summary: The study revealed that PD-L1 in ADC and PD-1+ TILs in SCC respectively indicate T-cell function, playing a crucial role in prognosis determination. PD-L1 was considered an independent predictor of overall survival for ADC patients, while PD-1+ TILs were deemed a poor prognostic predictor in SCC patients.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Oncology

Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3

Rui Ma, Yunpeng Liu, Xiaofang Che, Ce Li, Ti Wen, Kezuo Hou, Xiujuan Qu

Summary: Colorectal cancers with the BRAF V600E mutation have upregulated PD-L1 expression. This study found that PD-L1 is highly expressed in both the nucleus and cytoplasm. In the nucleus, PD-L1 translocation is facilitated by p-ERK and it interacts with THRAP3 to upregulate BUB1 expression, thus accelerating cell cycle progression and promoting cell proliferation. Additionally, BRAF V600E mutated CRC cells upregulate PD-L1 expression via the transcription factor LEF-1. These findings reveal a novel role of nPD-L1 in promoting cell cycle progression in an immune-independent manner in BRAF V600E mutated CRC.

CANCER LETTERS (2022)

Article Cell Biology

NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial-Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3

Jinqi Lv, Simeng Zhang, Yang Liu, Ce Li, Tianshu Guo, Shuairan Zhang, Zenan Li, Zihan Jiao, Haina Sun, Ye Zhang, Ling Xu

Summary: This study demonstrates that NR2F1-AS1/miR-190a/PHLDB2 promotes the phosphorylation of AKT3 to induce EMT in GC cells, providing a comprehensive understanding of the underlying mechanism involved in the EMT process and the identification of new EMT markers in gastric cancer.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Education, Scientific Disciplines

Construction of an immune-related gene signature to predict survival and treatment outcome in gastric cancer

Shuairan Zhang, Zhi Li, Hang Dong, Peihong Wu, Yang Liu, Tianshu Guo, Ce Li, Shuo Wang, Xiujuan Qu, Yunpeng Liu, Xiaofang Che, Ling Xu

Summary: The study identified 155 differentially expressed immune-related genes in patients with gastric cancer, with four genes closely associated with overall survival. These genes were found to be predictive of patient outcomes.

SCIENCE PROGRESS (2021)

Article Medicine, Research & Experimental

Upregulation of Serine Proteinase Inhibitor Clade B Member 3 (SERPINB3) Expression by Stromal Cell-Derived Factor (SDF-1)/CXCR4/Nuclear Factor kappa B (NF-κB) Promotes Migration and Invasion of Gastric Cancer Cells

Jing Gong, Yongxi Song, Ling Xu, Xiaofang Che, Kezuo Hou, Tianshu Guo, Yu Cheng, Yunpeng Liu, Xiujuan Qu

MEDICAL SCIENCE MONITOR (2020)

Article Oncology

RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR

Xing Wan, Yongxi Song, Honghong Fang, Ling Xu, Xiaofang Che, Shuo Wang, Xiaomeng Zhang, Lingyun Zhang, Ce Li, Yibo Fan, Kezuo Hou, Zhi Li, Xueqing Wang, Yunpeng Liu, Xiujuan Qu

CLINICAL AND TRANSLATIONAL MEDICINE (2020)

Article Oncology

Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods

Xiaofan Pu, Chaolei Zhang, Guoping Ding, Hongpeng Gu, Yang Lv, Tao Shen, Tianshu Pang, Liping Cao, Shengnan Jia

Summary: This study demonstrated the potential utility of the sEV-miRNA d-signature in the diagnosis of PDAC via machine learning methods. A novel sEV biomarker, miR-664a-3p, was identified for the diagnosis of PDAC. It can also potentially promote angiogenesis and metastasis, provide insight into PDAC pathogenesis, and reveal novel regulators of this disease.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Silencing of PD-1 combined with EBV-specific killer T cells for the treatment of EBV-associated B lymphoma

Jiaping Wang, Zhijuan Xu, Yanli Lai, Yanli Zhang, Ping Zhang, Qitian Mu, Shujun Yang, Yongcheng Sun, Lixia Sheng, Guifang Ouyang

Summary: This study demonstrates the significance of PD-1 in EBV-infected lymphoma cells. Silencing PD-1 enhances the tumor targeting effect of EBV-specific killer T cells on B lymphocytes and attenuates the immune escape effect.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer

Qiliang Peng, Jialong Tao, Yingjie Xu, Yi Shen, Yong Wang, Yang Jiao, Yiheng Mao, Yaqun Zhu, Yulong Liu, Ye Tian

Summary: This study investigates the potential role of lipid metabolism-associated genes (LMAGs) in neoadjuvant chemoradiotherapy (nCRT) and immunotherapy for rectal cancer. The results suggest that the SREBF2 gene is a highly predictive factor for nCRT in rectal cancer and is associated with favorable prognosis. SREBF2 is also closely associated with immune cell infiltration and immunotherapy-related genes.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Transcriptionally activates CCL28 expression to inhibit M2 polarization of macrophages and prevent immune escape in colorectal cancer cells

Shiquan Li, Nan Zhang, Yongping Yang, Tongjun Liu

Summary: This study investigated the potential molecular mechanism of SPDEF in immune evasion of colorectal cancer (CRC) and found that it suppresses immune evasion by activating CCL28 through the modulation of M2 polarization of macrophages. These findings provide a new research direction and potential therapeutic target for immunotherapy in CRC.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Characterizing heterogeneity along EMT and metabolic axes in colorectal cancer reveals underlying consensus molecular subtype-specific trends

Manas Sehgal, Soundharya Ramu, Joel Markus Vaz, Yogheshwer Raja Ganapathy, Srinath Muralidharan, Sankalpa Venkatraghavan, Mohit Kumar Jolly

Summary: This study investigates the relationship between gene expression patterns and phenotypic plasticity and heterogeneity in colorectal cancer (CRC). The results demonstrate the interconnectedness between different Consensus Molecular Subtypes (CMS) of CRC and specific phenotypes such as epithelial and mesenchymal characteristics. Additionally, the study reveals correlations between metabolic pathways and phenotypic scores, as well as between PD-L1 activity and mesenchymal phenotype. Single-cell RNA sequencing analysis further confirms the heterogeneity of different CMS subtypes. These findings have important implications for understanding CRC heterogeneity and developing targeted therapies.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Ceramide metabolism-related prognostic signature and immunosuppressive function of ST3GAL1 in osteosarcoma

Yutong Zou, Siyao Guo, Yan Liao, Weidong Chen, Ziyun Chen, Junkai Chen, Lili Wen, Xianbiao Xie

Summary: This study found that ceramide metabolism is associated with the progression and clinical outcome of osteosarcoma by analyzing data from osteosarcoma patients. The gene ST3GAL1 plays an important role in osteosarcoma, regulating the tumor immune microenvironment and affecting T cell function. It may become a new target for the treatment of osteosarcoma.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

GPR37-centered ceRNA network contributes to metastatic potential in lung adenocarcinoma: Evidence from high-throughput sequencing

Chuanhui Chen, Mengzhi Wan, Xiong Peng, Qing Zhang, Yu Liu

Summary: This study examines the function and mechanism of the ceRNA network centered around GPR37 in LUAD. The findings show that high expression of GPR37 in LUAD tissue samples is associated with poor prognosis, and it may regulate the expression of downstream target genes by competitively binding to lncRNA DLEU1 and miR-4458.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer

Junping Li, Hong Hu, Jinping He, Yuling Hu, Manting Liu, Bihui Cao, Dongni Chen, Xiaodie Ye, Jian Zhang, Zhiru Zhang, Wen Long, Hui Lian, Deji Chen, Likun Chen, Lili Yang, Zhenfeng Zhang

Summary: Sequential administration of CDC7 inhibitor XL413 after carboplatin enhances the chemotherapeutic effect of carboplatin on ovarian cancer cells, possibly by inhibiting homologous recombination repair activity and increasing the accumulation of chemotherapy-induced DNA damage.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Dual role of CASP8AP2/FLASH in regulating epithelial-to-mesenchymal transition plasticity (EMP)

Madison Catalanotto, Joel Markus Vaz, Camille Abshire, Reneau Youngblood, Min Chu, Herbert Levine, Mohit Kumar Jolly, Ana -Maria Dragoi

Summary: The study demonstrates that loss of FLASH in cancer cells leads to a hybrid E/M phenotype with high epithelial scores, suggesting FLASH acts as a repressor of the epithelial phenotype. Additionally, FLASH expression is inversely correlated with the epithelial score and subsets of mesenchymal markers are distinctly up-regulated in FLASH, NPAT, or SLBP-depleted cells.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Acetylation and deacetylation of histone in adipocyte differentiation and the potential significance in cancer

Xiaorui Wang, Na Li, Minying Zheng, Yongjun Yu, Shiwu Zhang

Summary: Adipocytes are derived from pluripotent mesenchymal stem cells and histone modifications play a key role in their differentiation. Recent studies have shown that cancer stem cells can differentiate into adipocytes, reducing the malignancy of cancer cells.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance

Hana Q. Sadida, Alanoud Abdulla, Sara Al Marzooqi, Sheema Hashem, Muzafar A. Macha, Ammira S. Al-Shabeeb Akil, Ajaz A. Bhat

Summary: Cancer heterogeneity and drug resistance are major obstacles to effective cancer treatment, and epigenetic modifications play a pivotal role in these processes. This review explores essential epigenetic modifications, including DNA methylation, histone modifications, and chromatin remodeling, and discusses their complex contributions to cancer biology. However, the interplay of epigenetic and genetic changes in cancer cells presents unique challenges that must be addressed to fully exploit the potential of epigenetic modifications.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC

Pedro De Marchi, Leticia Ferro Leal, Luciane Sussuchi da Silva, Rodrigo de Oliveira Cavagna, Flavio Augusto Ferreira da Silva, Vinicius Duval da Silva, Eduardo C. A. da Silva, Augusto O. Saito, Vladmir C. Cordeiro de Lima, Rui Manuel Reis

Summary: The TIS and IFN-gamma signatures are predictive biomarkers for identifying NSCLC patients who could potentially benefit from immune checkpoint inhibitor therapies.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence

Giovanni Marchi, Anna Rajavuori, Mai T. N. Nguyen, Kaisa Huhtinen, Sinikka Oksa, Sakari Hietanen, Sampsa Hautaniemi, Johanna Hynninen, Jaana Oikkonen

Summary: The study shows that ctDNA can adequately represent high-grade serous ovarian carcinoma (HGSC), and the mutations observed at relapse suggest personalized therapy options.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models

Yuncang Yuan, Jiawei Fan, Dandan Liang, Shijie Wang, Xu Luo, Yongjie Zhu, Nan Liu, Tingxiu Xiang, Xudong Zhao

Summary: This study demonstrates that csGRP78-directed CAR-T cells can selectively kill pancreatic cancer cells, and the combination with chemotherapy enhances cytotoxicity.

TRANSLATIONAL ONCOLOGY (2024)

Article Oncology

Bulky glycocalyx shields cancer cells from invasion-associated stresses

Niyati Piplani, Tanusri Roy, Neha Saxena, Shamik Sen

Summary: The glycocalyx, a protective barrier surrounding cells, has been found to play a role in cancer cell proliferation, survival, and metastasis. However, its function in maintaining DNA/nuclear integrity during migration through dense matrices has not been explored. This study shows that the bulkiness of the glycocalyx is inversely associated with nuclear stresses, and highlights its mechanical role in shielding migration-associated stresses.

TRANSLATIONAL ONCOLOGY (2024)